Wed, October 18, 2023
Tue, October 17, 2023
Mon, October 16, 2023
Sun, October 15, 2023
Fri, October 13, 2023
Thu, October 12, 2023
Wed, October 11, 2023

David Westenberg Maintained (AKYA) at Buy with Decreased Target to $11 on, Oct 16th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-11-on-oct-16th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Westenberg of Piper Sandler, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $14 to $11 on, Oct 16th, 2023.

David has made no other calls on AKYA in the last 4 months.



There are 3 other peers that have a rating on AKYA. Out of the 3 peers that are also analyzing AKYA, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • John Sourbeer of "UBS" Maintained at Strong Buy with Decreased Target to $7 on, Thursday, October 12th, 2023
  • Mason Carrico of "Stephens & Co." Reiterated at Buy and Held Target at $16 on, Tuesday, August 8th, 2023
  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $15 on, Tuesday, August 8th, 2023

Publication Contributing Sources